We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sign up to read this article for FREE!

After signing up, you'll start to receive regular news updates from us.

Helicos BioSciences Announces Genome Sequencing Using True Single Molecules

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Helicos BioSciences has announced that it has sequenced the M13 genome, by utilizing its non-amplified True Single Molecule Sequencing (tSMS™) technology in conjunction with its SimplePrep™ genome preparation technique.

Sequencing of M13 was conducted on the entire genome, including so-called homopolymeric sequences.

"This marks an unprecedented achievement," said Stanley N. Lapidus, President and CEO of Helicos BioSciences.

"Helicos is the only organization to have successfully sequenced a genome using tSMS™ technology - an accomplishment we've worked hard to achieve."

He added, "The simplicity of tSMS™ in working directly from genomic DNA and eliminating amplification, provides researchers with unparalleled advantages, potentially enabling them to represent the entire human genome on a single glass substrate - and to sequence it in a day, and not years."